INECO Neurociencias Oroño - Rosario

INECO Neurociencias Oroño - Rosario
Bv. Oroño 1508, Rosario, Santa Fe
Select an option

Our team

Medical staff
Marisa Vico
Yamila Margaria
Dr. Oviedo
Maria Cecilia Bahit
Keila Schwindt
Alvaro Gallegos
Maria de los Milagros Arce
Micaela Ruarte
Florencia Garavelli
Juana Torres
Cappiello Florencia

Open studies

Obesity
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity - MARITIME-CV - AmgenSee more
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity - MARITIME-HF - AmgenSee more
Multiple Sclerosis
A Study to Assess Bioequivalence of Two Subcutaneous (SC) Formulations of Ocrelizumab in Participants With Multiple Sclerosis (MS) - PORTAMENTO - Hoffmann-La RocheSee more
Cardiovascular disease
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity - MARITIME-CV - AmgenSee more
Migraine
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine - PROSPECT-1 - H. Lundbeck A/SSee more
Heart failure
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity - MARITIME-HF - AmgenSee more
Polyneuropathy
A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP - emvigorate - argenxSee more
Myasthenia gravis
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad) - MyClad - Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, GermanySee more
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy